Can Chemoradiotherapy Expand Immune Checkpoint Blockade Responsiveness in Mismatch Repair‐Proficient Rectal Cancer?

Kimihiro Yamashita, Takeru Matsuda, Junko Mukohyama, Ryohei Sasaki, Yoshihiro Kakeji · 2026

Read Can Chemoradiotherapy Expand Immune Checkpoint Blockade Responsiveness in Mismatch Repair‐Proficient Rectal Cancer? by Kimihiro Yamashita, Takeru Matsuda, Junko Mukohyama, Ryohei Sasaki, Yoshihiro Kakeji (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13579431.txt.

Description

Kimihiro Yamashita and four co-authors ask whether chemoradiation can wake immune drugs in rectal cancer in a 2026 review. Immune brake drugs remade care for bowel cancers with broken repair genes, yet they give near no gain when repair genes work. In rectal cancer of that kind, early hints break the rule.

Trials that add the brake drug to chemoradiation before surgery saw full tumor loss in three of ten or more cases, past chemoradiation alone. Lasting full loss may let some patients skip surgery and watch instead. The review weighs the proof and the open asks.

Catalog record

CREATORKimihiro Yamashita, Takeru Matsuda, Junko Mukohyama, Ryohei Sasaki, Yoshihiro Kakeji
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE23 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13579431

Browse the full library · About the Tower of Babel